Help
This page guides users through eVGeMdb. Please scroll through the User Manual for detailed instructions.
Genetic Modifiers: Genes that can affect the phenotypic expression of primary disease-causing genes.
Target Gene/Protein: The primary gene or protein whose function or dysfunction is associated with the disease, (e.g., TDP-43 in ALS, A-beta in Alzheimer’s).
Disease Model: The experimental system (e.g., cell line, yeast, worm, mice) used to identify genetic modifiers.
Phenotype: The biological outcome observed in the disease model due to altered modifier genes.
Screen: The experimental strategies used to modify candidate modifier genes.
Type of Modification: The event caused in the modifier gene to see its effect.
Effect: Direction of modification: Suppression (reduces toxicity), Enhancement (increases toxicity),
Suppression: As per the designed experiment, the modifier gene shows the reduction of the disease phenotype.
Enhancement: As per the designed experiment, the modifier gene shows the increased disease phenotype.
Human Ortholog: Human gene corresponding to the modifier gene.
Targeted Drugs: Drugs from DrugBank that target the human ortholog of the modifier genes.
PMID : PubMed ID of the publication from which this modifier was curated.
Current version= eVGeMdb v1.0: Publications till June 2025
This version catalogs over 17,000 genetic modifiers for major neurodegenerative disorders, including Amyotrophic Lateral Sclerosis(ALS), Alzheimer's disease(AD), Parkinson's disease(PD), Huntington’s disease(HD), and Ataxia.
For any queries, please submit this form.